Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Clinical trial NCT07177352 · RECRUITING

Trial details

NCT number: NCT07177352
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimers Disease

Start date: 2025-07-02
Primary completion: 2035-07-31
Enrollment: 80000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.